Glenmark Adds Pain Rxs

February 2011
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p62
Trade Publication
The article reports on the reestablishment of Glenmark Generics Inc. USA's pain management portfolio by launching two oxycodone hydrochloride formulations in the U.S.


Related Articles

  • Glenmark US arm reaches settlement with Texas.  // FRPT- Chemical Snapshot;4/26/2015, p10 

    The article presents information on the settlement between Glenmark Generics Inc. and the State of Texas in relation to a pricing investigation conducted by the Texas Attorney General.

  • Glenmark Tabs Sales Director.  // Chain Drug Review;10/24/2011, Vol. 33 Issue 18, p86 

    The article announces that Glenmark Generics Inc. USA has appointed Jolene McGilliard as its sales director.

  • Glenmark Generics Inc.  // Chain Drug Review;9/26/2011, Vol. 33 Issue 16, p86 

    The article profiles Glenmark Generics Inc. USA, which is dedicated to the manufacturing, marketing, and distribution of generic pharmaceutical products in the U.S.

  • Glenmark Generics Inc.  // Chain Drug Review;9/24/2012, Vol. 34 Issue 16, p132 

    The article profiles the generic pharmaceuticals company, Glenmark Generics Inc. USA, located in Mahwah, New Jersey.

  • Glemark Generics.  // Chain Drug Review;9/30/2013, Vol. 35 Issue 15, p114 

    The article offers information on Glenmark Generics Inc. USA, the North American division of Glenmark Generics Ltd., dedicated to the distribution of generic pharmaceutical products, and is having 55 pending approval of Abbreviated New Drug Application (ANDA) from the Food and Drug Administration.

  • Glenmark Wins Approval For Equivalent of Lybrel.  // Chain Drug Review;4/27/2015, Vol. 37 Issue 7, p249 

    The article reports on the approval received by Glenmark Pharmaceuticals Ltd. subsidiary Glenmark Generics Inc. USA from the U.S. Food and Drug Administration (FDA) of the Abbreviated New Drug Application (ANDA) for its generic levonorgestrel and ethinyl estradiol tablets.

  • Glenmark Generics receives final ANDA approval for Omeprazole DR capsules.  // Express Pharma;10/01/2014, p3 

    The article reports on the approval of the U.S. Food and Drug Administration (FDA) for the abbreviated new drug application (ANDA) of Indian pharmaceutical company Glenmark Generics Inc. for its Omeprazole delayed release capsules.

  • Glenmark receives final ANDA approval.  // BioSpectrum;Sep2013, Vol. 11 Issue 9, p24 

    The article reports that Glenmark Generics Inc. USA has received the final Abbreviated New Drug Approval (ANDA) from the U.S. Food and Drug Administration for Acamprosate Calcium Delayed Release Tablets for maintenance of abstinence from alcohol dependence.

  • Glenmark Wins FDA Approval.  // Chain Drug Review;7/19/2010, Vol. 32 Issue 12, p63 

    The article reports on the approval granted by the Food and Drug Administration (FDA) to Glenmark Generics Inc. USA for three strengths of verapamil hydrochloride and trandolapril extended-release tablets in 2010.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics